London Daily

Focus on the big picture.
Saturday, Aug 02, 2025

AstraZeneca's logo is reflected in a drop on a syringe needle in this illustration

Britain to become first country to trial AstraZeneca coronavirus antibody treatment

New antibody combination aims to help people with weakened immune systems
A new coronavirus antibody treatment developed by pharmaceutical giant AstraZeneca will begin clinical trials for the first time in the UK.

A volunteer from Wakefield, West Yorkshire, will become the first person in the world to receive the company’s new “antibody cocktail”, which is aimed at people with a weakened immune system who cannot be vaccinated.

The clinical trial programme will test whether the treatment will prevent Covid-19 for up to a year. It will evaluate the safety and effectiveness of a combination of two long-acting monoclonal antibodies, which are man-made proteins that act like natural human antibodies in the immune system.

5,000 volunteers will be recruited into the trial, including 1,000 people from nine sites in the UK.

Sir Mene Panaglos, executive vice president of biopharmaceutical research and development at AstraZeneca, said: “There is going to be a significant number of people - even in a world where vaccines are highly effective - who will not respond to vaccines, or in fact will not take vaccines.

“So having monoclonal antibodies as potential therapeutics is also important.”

He called for people, especially vulnerable people over the age of 60 who are immuno-suppressed, to sign up to the trial. These will include people from health care and care home settings.

The UK Government agreed in principle to secure access to one million doses of the antibody treatment, dubbed AZD7442, if it produces successful results in the phase three trials.

Kate Bingham, chairwoman of the UK’s Vaccine Taskforce, said the treatment will be part of the UK’s Covid protection portfolio.

“So, obviously, vaccines work in people who have a functional immune system,” she said. “[But] if you are immuno-suppressed, and you are going through bone marrow transplants, or indications or treatments that actually reduce your ability to mount an immune response, then this is basically the only current way of providing that short-term passive immunity.

“So we are absolutely looking to protect those people who are immuno-suppressed or those people who need immediate protection, because you will remember that vaccines typically take about six weeks to work.”

The NHS Vaccine Research Registry, which comprises a list of 340,000 volunteers willing to take part in clinical trials, will provide some patients for AstraZeneca’s trial.

Sir Mene explained that the two antibodies have been engineered with a life-extension technology to make them effective for longer.

Scientists think the combination will provide protection for at least six months, but closer to 12 months. He described it as a “passive vaccination”.

It is unclear how much the treatment will cost, but Sir Mene said it will be “more expensive than vaccines”, adding: “We hope to make it cost-effective.”

Alok Sharma, the business aecretary, said in a statement: “I am very proud that the UK is the first country in the world to begin this invaluable study, and that a fifth of trial volunteers will be from Britain - a testament to our fantastic life sciences sector and the willingness of our people to come forward to help others.

“As we move closer to a Covid-19 vaccine, we must keep driving forward clinical trials for new and alternative treatments that protect our vulnerable, particularly those who cannot receive a vaccine.

“That is why we have procured one million doses of AstraZeneca’s long-acting antibody treatment if it meets robust safety and effectiveness standards.”
Newsletter

Related Articles

0:00
0:00
Close
Trump Administration Finalizes Broad Tariff Increases on Global Trade Partners
J.K. Rowling Limits Public Engagements Citing Safety Fears
JD.com Launches €2.2 Billion Bid for German Electronics Retailer Ceconomy
Azerbaijan Proceeds with Plan to Legalise Casinos on Artificial Islands
Former Judge Charged After Drunk Driving Crash Kills Comedian in Brazil
Jeff Bezos hasn’t paid a dollar in taxes for decades. He makes billions and pays $0 in taxes, LEGALLY
China Increases Use of Exit Bans Amid Rising U.S. Tensions
IMF Upgrades Global Growth Forecast as Weaker Dollar Supports Outlook
Procter & Gamble to Raise U.S. Prices to Offset One‑Billion‑Dollar Tariff Cost
House Republicans Move to Defund OECD Over Global Tax Dispute
Botswana Seeks Controlling Stake in De Beers as Anglo American Prepares Exit
Trump Administration Proposes Repeal of Obama‑Era Endangerment Finding, Dismantling Regulatory Basis for CO₂ Emissions Limits
France Opens Criminal Investigation into X Over Algorithm Manipulation Allegations
A family has been arrested in the UK for displaying the British flag
Mel Gibson refuses to work with Robert De Niro, saying, "Keep that woke clown away from me."
Trump Steamrolls EU in Landmark Trade Win: US–EU Trade Deal Imposes 15% Tariff on European Imports
ChatGPT CEO Sam Altman says people share personal info with ChatGPT but don’t know chats can be used as court evidence in legal cases.
The British propaganda channel BBC News lies again.
Deputy attorney general's second day of meeting with Ghislaine Maxwell has concluded
Controversial March in Switzerland Features Men Dressed in Nazi Uniforms
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
Thai Civilian Death Toll Rises to 12 in Cambodian Cross-Border Attacks
TSUNAMI: Trump Just Crossed the Rubicon—And There’s No Turning Back
Over 120 Criminal Cases Dismissed in Boston Amid Public Defender Shortage
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
Trump Announces $550 Billion Japanese Investment and New Trade Agreements with Indonesia and the Philippines
US Treasury Secretary Calls for Institutional Review of Federal Reserve Amid AI‑Driven Growth Expectations
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Severe Flooding in South Korea Claims Lives Amid Ongoing Rescue Operations
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Japanese Prime Minister Vows to Stay After Coalition Loses Upper House Majority
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
CEO Resigns Amid Controversy Over Relationship with HR Executive
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
×